# US 2025/0154535 A1 · Disruption of cdc42 effectors in yeast for increased alcohol and lysine production

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0154535 A1
- Document ID: US20250154535A1
- Status: Published application
- Kind: A1
- Application number: 19/025,571
- Filed: 2025-01-16
- Published: 2025-05-15
- Earliest claimed: 2019-06-24
- Assignees: Danisco US Inc.
- Applicants: Danisco US Inc.
- Inventors: Jaclyn Diana DeMartini; Celia Emily Gaby Payen
- Web page: https://patentgrep.com/patent/US20250154535A1

## CPC

- C07K 14/395: from Saccharomyces
- C12P 7/06: Ethanol, i.e. non-beverage
- C10L 1/02: essentially based on components consisting of carbon, hydrogen, and oxygen only
- C12N 1/18: Baker's yeast; Brewer's yeast
- C12N 15/52: Genes encoding for enzymes or proenzymes
- C12N 15/81: for yeasts
- C12P 13/08: Lysine; Diaminopimelic acid; Threonine; Valine
- C12Y 102/0101: Acetaldehyde dehydrogenase (acetylating) (1.2.1.10)
- C12Y 203/01008: Phosphate acetyltransferase (2.3.1.8)
- C12Y 401/02009: Phosphoketolase (4.1.2.9)
- C10L 2200/0469: Renewables or materials of biological origin
- C10L 2290/26: Composting, fermenting or anaerobic digestion fuel components or materials from which fuels are prepared
- C12N 2800/102: for yeast
- Y02E 50/10: Biofuels, e.g. bio-diesel
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- C12P: FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer C12C; producing vinegar C12J; producing specific peptides or proteins C07K; producing enzymes C12N9/00; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; measuring or testing processes involving enzymes or microorganisms C12Q; measuring or testing processes involving nucleic acid amplification reactions C12Q1/6844; fermentation processes to form a food composition, A21 or A23; compounds in general, see the relevant compound class, e.g. C01, C07)}
- C10L: FUELS NOT OTHERWISE PROVIDED FOR; NATURAL GAS; SYNTHETIC NATURAL GAS OBTAINED BY PROCESSES NOT COVERED BY SUBCLASSES C10G OR C10K; LIQUIFIED PETROLEUM GAS; USE OF ADDITIVES TO FUELS OR FIRES; FIRE-LIGHTERS
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12Y: ENZYMES
- Y02E: REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION

## Abstract

Described are compositions and methods relating to yeast having a genetic mutation that results in decreased amounts of Cdc42 effector proteins, resulting in increased alcohol and lysine production. Such yeast is well-suited for use commercial alcohol production to increase yields and to increase the value of Such yeast is well-suited for use commercial alcohol production to increase yields and to increase the value of amino-acid-containing, fermentation-co-products.

## Claims

### Claim 1

A method for producing a modified yeast cell comprising: introducing a genetic alteration into a parental yeast cell, which genetic alteration reduces or prevents the production of functional Cdc42 effector polypeptides compared to the parental cells, thereby producing modified yeast cells that produce during fermentation an increased amount of alcohol and/or lysine compared to the parental cells under equivalent fermentation.

### Claim 2 (depends on 1)

The method of claim 1, wherein the genetic alteration reduces or prevents the production of functional Gic1 and/or Gic2 polypeptides compared to the parental cells.

### Claim 3 (depends on 1)

The method of claim 1, wherein the modified yeast cells produce a reduced amount, or do not produce a measurable amount of, Gic1 and/or Gic2 polypeptides.

### Claim 4 (depends on 1, 2, 3)

The method of any one of claims 1-3, wherein the genetic alteration comprises a disruption of a YHR061c gene, or homolog, thereof, encoding a Gic1 polypeptide and/or disruption of a YDR309c gene, or homolog, thereof, encoding a Gic2 polypeptide, present in the parental cells.

### Claim 5 (depends on 4)

The method of claim 4, wherein the disruption is the result of deletion of all or part of the YHR061c gene, or homolog, thereof, and/or a YDR309c gene, or homolog, thereof, respectively.

### Claim 6 (depends on 4)

The method of claim 4, wherein the disruption is the result of deletion of a portion of genomic DNA comprising the YHR061c gene, or homolog, thereof, and/or the YDR309c gene, or homolog, thereof, respectively.

### Claim 7 (depends on 4)

The method of claim 4, wherein the disruption is the result of mutagenesis of the YHR061c gene, or homolog, thereof, and/or the YDR309c gene, or homolog, thereof, respectively.

### Claim 8 (depends on 4, 5, 6, 7)

The method of any one of claims 4-7, wherein disruption of the YHR061c gene, or homolog, thereof, and/or the YDR309c gene, or homolog, thereof, respectively, is performed in combination with introducing a gene of interest at a corresponding genetic locus.

### Claim 9 (depends on 1, 2, 3, 4, 5, 6, 7, 8)

The method of any one of claims 1-8, wherein the modified yeast cells further comprise one or more genes of the phosphoketolase pathway.

### Claim 10 (depends on 9)

The method of claim 9, wherein the genes of the phosphoketolase pathway are selected from the group consisting of phosphoketolase, phosphotransacetylase and acetylating acetyl dehydrogenase.

### Claim 11 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10)

The method of any one of claims 1-10, wherein the modified yeast cells further comprise an exogenous gene encoding a carbohydrate processing enzyme.

### Claim 12 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11)

The method of any one of claims 1-11, wherein the modified yeast cells further comprise an alteration in the glycerol pathway and/or the acetyl-CoA pathway.

### Claim 13 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12)

The method of any one of claims 1-12, wherein the modified yeast cells further comprise an alternative pathway for making ethanol.

### Claim 14 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13)

The method of any of claims 1-13, wherein the modified yeast cells are of a Saccharomyces spp.

### Claim 15

A method for increasing the amount of lysine present in a post-fermentation product, comprising:
(i) hydrolyzing a starch-containing feedstock with an α-amylase to produce a starch liquefact;
(ii) saccharifying the starch liquefact with a glucoamylase to produce glucose;
(iii) fermenting the glucose with modified yeast cells derived from parental yeast cells, the modified yeast cells comprising a genetic alteration that causes the production of decreased amounts of functional Cdc42 effector polypeptides compared to the parental cells; and
(iv) recovering a post-fermentation by-product enriched for lysine compared to post-fermentation by-product recovered from an otherwise identical process using the parental yeast.

### Claim 16 (depends on 15)

The method of claim 15, wherein the post-fermentation by-product is selected from the group consisting of fermentation broth, whole stillage, thin stillage, distillers dried grains, distillers dried grains with solutes, condensed distillers solubles or other protein-containing coproducts.

### Claim 17 (depends on 15, 16)

The method of claim 15 or claim 16, wherein one or more steps (i)-(iv) are combined, simultaneous or over-lapping.

### Claim 18

A method for increasing the amount of lysine present in a fermentation product, comprising:
(i) fermenting glucose or another sugar with modified yeast cells derived from parental yeast cells, the modified yeast cells comprising a genetic alteration that causes the production of decreased amounts of functional Cdc42 effector polypeptides compared to the parental cells; and
(ii) recovering fermentation product enriched for lysine compared to a fermentation product recovered from an otherwise identical process using the parental yeast.

### Claim 19 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14)

Modified yeast cells produced by the method of any of claims 1-14.

### Claim 20 (depends on 18)

A fermentation product produced by the method of claim 18.

### Claim 21 (depends on 15, 16, 17)

A post-fermentation by-product produced by the method of any one of claims 15-17.
